|
|
|
|
|
|
|
Poster: 6
Visits: 96
Title: Durvalumab With Or Without Bevacizumab As Adjuvant Therapy For HCC Patients At Risk Of Recurrence After Curative Therapy: EMERALD-2
Authors: Jennifer Knox ,
Centre:
|
|
You must be registered to reply or comment.
|
|
DURVALUMAB WITH OR WITHOUT BEVACIZUMAB AS ADJUVANT THERAPY FOR HCC PATIENTS AT RISK OF RECURRENCE AFTER CURATIVE THERAPY: EMERALD-2
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre:
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 3
Visits: 186
Title: Ramucirumab For Patients With Advanced Hepatocellular Carcinoma And Elevated Alpha Fetoprotein Following A Non-Sorafenib Based Systemic Therapy: Interim Results From An Expansion Cohort Of The Phase 3 Reach-2 Study
Authors: David Mcilwain ,
Centre:
|
|
|
|